Navigation Links
Current Blood Thinners Face Tough Competition
Date:2/26/2010

Studies provide more evidence that newcomers hold mettle against warfarin, aspirin

FRIDAY, Feb. 26 (HealthDay News) -- New studies provide more proof that the mainstays of anti-clotting therapy, namely warfarin and aspirin, are facing some severe competition from newcomers.

Researchers presenting their findings during a Friday news conference at the American Stroke Association's annual meeting in San Antonio show that one new drug, dabigatran (Pradaxa), which is not yet approved in the United States, equaled warfarin for treating stroke patients, while cilostazol (Pletal), which has been approved by the U.S. Food and Drug Administration for the treatment of peripheral arterial disease (PAD), outperformed aspirin in preventing recurrent strokes.

Other researchers presented evidence that high-intensity movement exercise assisted by a robot or a human can improve functioning and quality of life in stroke survivors years after the event. It has long been thought that improvements could only be garnered in the early days following a stroke.

The Pradaxa trial included 3,623 patients with atrial fibrillation and a previous stroke who were randomized to receive warfarin, a low dose of Pradaxa (110 milligrams) twice a day or a higher dose (150 mg) of Pradaxa twice a day for about two years.

The rate of stroke or transient ischemic attack (TIA) in those taking warfarin was 2.74 percent a year and 2.32 percent a year for those taking Pradaxa, not a significant difference.

The lower dose of Pradaxa also caused less bleeding and was easier to manage than warfarin, a famously difficult drug to administer and monitor.

"In contrast to warfarin, dabigatran is given in a fixed dose twice daily independent of body weight, sex, food, whatever, and you don't need to monitor the coagulation system," study author Dr. Hans-Christoph Diener, chairman of neurology at University Hospital in Essen, Germany, sa
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mesothelioma Clinical Trials List Offered by IQ Mesothelioma: Search Current Mesothelioma Treatment Options
2. Children can have recurrent strokes
3. OnlineEducation.com Announces the Addition of Fully Accredited Law and Criminal Justice Degree Programs to its Current Website Offerings
4. Current Smoking Can Worsen Lung Cancer
5. Is Obesity a Disease? Current Research, Facts, Figures, and the Pros and Cons at New ProCon.org Website
6. American Scientific CE Removed - Now Current Information
7. CAHU and NAHU Weigh in on Current Form of H. R. 3590
8. Anthem Blue Cross and Blue Shield In Missouri Urges Missouri Senators Claire McCaskill and Christopher S. Bond to Not Support the Current Senate Health Care Reform Legislation
9. Connectyx Attains Current Listing Status on Pink Sheets Exchange
10. National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short In Addressing Cancer Care Crisis
11. National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short in Addressing Cancer Care Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... 2015 , ... Dermatologists from the Mount Sinai Health System ... possible melanomas and 46 potential non-melanoma skin cancers (basal cell and squamous cell ... Ideas Festival, which was held from June 25 through July 4, 2015, in ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... that the two firms have merged to form Camber Collective. Camber Collective ... sectors. The merger combines SwitchPoint’s strategy consulting expertise with Hope Consulting’s deep ...
(Date:7/7/2015)... IL (PRWEB) , ... July 07, 2015 , ... ... the only industry group whose board is limited to permit holders. The Medical ... on how to move the industry forward and are committed to making sure ...
(Date:7/7/2015)... ... ... Summer is a great time to get outside and be active. It’s ... tips. , Jean Tapley, senior wellness coordinator at Amica, suggests the following seven tips ... Start slowly. Going from no activity to several hours of activity can potentially be ...
(Date:7/7/2015)... ... 2015 , ... On June 22nd-26th, 2015, the Cobo Convention ... Baptist Convention 110th Annual Session of the National Baptist Congress of Christian Education ... and their congregations, medical professionals and health-related organizations, this week long event included ...
Breaking Medicine News(10 mins):Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3
... 6 Osteotech, Inc.,(Nasdaq: OSTE ) announced today ... million from third quarter 2006 revenue of $23.4,million. Revenue ... $17.6 million for the three months ended September 30,2007 ... same segments for the,third quarter of 2006. Gross margin ...
... Thursday, November 8,2007, at 8:30 a.m. Eastern/2:30 p.m. Central ... CTIC and MTAX: CTIC),management team will host ... quarter achievements and financial results. Conference Call ... a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time ...
... Nov. 6 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ... September 30, 2007. For the third quarter of 2007, ... share, compared to a net loss of $11.4 million, or,$0.46 ... shares,outstanding for the third quarters of 2007 and 2006 were ...
... - Elsevier Signs Agreement With Bayer HealthCare ... healthcare company, Bayer,HealthCare AG, headquartered in Leverkusen, Germany, ... in electronic format for,the first time, EMBASE Classic ... Excerpta Medica Abstract Journals published between 1947 and,1973. ...
... NASDAQ: CRME TSX: COM, VANCOUVER, Nov. 5 /PRNewswire-FirstCall/ ... announced that Bob Rieder, Chairman and,Chief Executive Officer, will ... Annual Healthcare Conference in New York at 1:20pm Eastern,Time ... A live webcast of Mr. Rieder,s presentation can be ...
... Nov. 5 StatSure Diagnostic,Systems, Inc. (OTC Bulletin ... Drug Administration ("FDA"), through its Center for Devices ... Clinical Laboratory,Improvements Amendments of 1988 ("CLIA") for an ... technology. The HIV 1/2 product,is marketed and distributed ...
Cached Medicine News:Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 2Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 3Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 4Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 5Health News:Rigel Announces Third Quarter 2007 Financial Results 2Health News:Rigel Announces Third Quarter 2007 Financial Results 3Health News:Rigel Announces Third Quarter 2007 Financial Results 4Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 2Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 3Health News:Cardiome to Present at CIBC Conference 2Health News:Cardiome to Present at CIBC Conference 3Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 3
(Date:7/7/2015)... 7 de julio de 2015 Sequent ... privada centrada en el desarrollo de dispositivos innovadores ... anunciado hoy que R. Michael Kleine ... Kleine cuenta con más de 25 ... dispositivos médicos y la sanidad. Ha gestionado con ...
(Date:7/7/2015)... , July 7, 2015 According to ... Method (Manual, Automated), Product (Consumables, Instrument), Application (Aerobic, Anaerobic, Yeast/ ... Research Institute) - Forecast to 2019", published by MarketsandMarkets, The ... Million by 2019 from $2,750.2 Million in 2014 at a ... 1 78 ma rket data ...
(Date:7/7/2015)... Accelovance, Inc. (Accelovance), a global contract ... General Medicine announced the completion of enrollment and ... Therapeutics, Inc. for the Phase 3 trial of ... SUSTOL® (granisetron injection, extended release) as part of ... receptor antagonist fosaprepitant and IV corticosteroid dexamethasone ...
Breaking Medicine Technology:Sequent Medical nombra a Mike Kleine a su junta directiva 2Sequent Medical nombra a Mike Kleine a su junta directiva 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 2Blood Culture Tests Market Worth $3,893.5 Million by 2019 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 4Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... WIRE)--May 15, 2007 - Synthetic Blood,International, Inc. ... analysis of its Phase IIa study with ... line with preliminary,study results announced in December ... of increasing patients' oxygen,tension levels compared with ...
... WIRE)--May 17, 2007 - Salix,Pharmaceuticals, Ltd. (NASDAQ:SLXP) today ... the Company's products,will be presented at Digestive Disease ... Digestive Disease Week is considered the,largest and most ... Every year it attracts more than 16,000 physicians,researchers ...
Cached Medicine Technology:Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5
The Heat Sealing Foil and Heat...
... A self-contained work area that will ... Dual UV bulbs irradiate the work area ... contaminating DNA will be amplified. Containment features ... non-ventilated hood has acrylic windows for a ...
PCR Workstation brings together UV irradiation and antimicrobial stainless steel to create a dual-attack environment against PCR contamination. PCR Workstation now available with a UV/Air Circulator ...
Remote Alpha Dock system for the DNA Engine line, allows, Alpha unit to function remotely (requires fan power supply)...
Medicine Products: